Surrogacy and Genetic Technology Overlap

Introduction

Surrogacy and genetic technology overlap when assisted reproductive procedures use genetic testing, embryo screening, genetic diagnosis or gene-editing technologies to assist intended parents in having a child through a surrogate mother. These technologies may help identify inherited disorders, examine embryo health and understand genetic relationships between intended parents and children.

However, this overlap creates complex legal and ethical questions concerning reproductive autonomy, informed consent, genetic privacy, embryo ownership, parental rights and the welfare of children. In India, there is no separate law exclusively governing the intersection of surrogacy and genetic engineering. The subject is regulated through surrogacy legislation, ART legislation, constitutional principles and biomedical research guidelines.

Legal and Regulatory Framework in India

1. Surrogacy (Regulation) Act, 2021: Section 4 establishes eligibility and medical conditions for surrogacy. Section 6 requires the surrogate mother's written informed consent. Section 7 prohibits abandonment of a child born through surrogacy because of genetic defects, birth defects or other medical conditions. Section 8 provides legal recognition to the child as the biological child of the intending couple or intending woman.

India Code

2. Assisted Reproductive Technology (Regulation) Act, 2021: This legislation regulates ART clinics, gamete banks, embryo handling and reproductive procedures. It establishes requirements for registration, consent, record maintenance and the responsible use of reproductive technologies.

IndiaCode+1

3. ICMR–DBT National Guidelines for Stem Cell Research, 2017: These guidelines restrict human germline gene therapy and reproductive cloning. They establish ethical boundaries for embryo research and genetic manipulation. Therefore, a private surrogacy agreement cannot independently authorise prohibited genetic experimentation.

4. Article 21 of the Constitution: Protects privacy, dignity and reproductive autonomy. Genetic information and reproductive decisions must be handled consistently with constitutional protections.

Important Case Laws

1. Baby Manji Yamada v. Union of India (2008) 13 SCC 518

The Supreme Court considered legal issues arising from an international commercial surrogacy arrangement involving a Japanese couple and an Indian surrogate mother. The dispute raised questions concerning custody, parentage and the legal status of a child born through surrogacy. Although genetic engineering was not involved, the judgment is relevant to disputes concerning genetic parenthood and the legal protection of surrogate-born children.

PMC+1

2. Jan Balaz v. Anand Municipality (2009)

The Gujarat High Court considered citizenship and parentage issues concerning twins born through an Indian surrogacy arrangement for German intended parents. The case demonstrated the difficulties that arise when genetic parentage, gestational motherhood and nationality involve different legal systems. Its principles are relevant to cross-border reproductive technology disputes.

ICSI+1

3. Suchita Srivastava v. Chandigarh Administration (2009) 9 SCC 1

The Supreme Court recognised reproductive choice as an important aspect of personal liberty under Article 21. The judgment is relevant to the autonomy of women in reproductive decisions, including decisions involving assisted reproductive procedures and pregnancy.

4. Vijaya Kumari S. v. Union of India (2025 INSC 1209)

The Supreme Court examined the application of age restrictions under the Surrogacy (Regulation) Act, 2021, to intending couples who had already created and frozen embryos before the Act came into force. It recognised the importance of reproductive autonomy and held that the statutory age restrictions could not retrospectively defeat qualifying surrogacy procedures already commenced. This decision is particularly relevant to disputes involving frozen embryos and changing reproductive technologies.

VoxJuris+1

Major Legal Issues

Genetic modification: Reproductive gene editing raises serious ethical and regulatory restrictions, particularly where changes may be inherited by future generations.

Informed consent: Intended parents and surrogate mothers must receive appropriate information about medical procedures and risks.

Genetic privacy: Genetic test results must be protected against unauthorised disclosure or misuse.

Parental responsibility: A child cannot be rejected or abandoned because of genetic abnormalities.

Medical liability: Clinics may face legal consequences for negligence, unauthorised embryo manipulation or violations of statutory requirements.

Conclusion

The overlap between surrogacy and genetic technology represents an important developing area of Indian biotechnology and reproductive law. The Surrogacy (Regulation) Act, 2021 and ART Act, 2021 regulate reproductive procedures and protect the interests of surrogate mothers and children, while biomedical guidelines restrict certain forms of genetic manipulation. Future legal development must balance scientific progress with reproductive autonomy, informed consent, genetic privacy and the welfare of children.